Diagnosis and Treatment of Hepatocellular Carcinoma

Gastroenterology

Volumn 134, Issue 6, 2008, Pages 1752-1763

  El Serag, Hashem B ^a   Marrero, Jorge A ^b   Rudolph, Lenhard ^d   Reddy, K Rajender ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; ERLOTINIB; GEMCITABINE; OXALIPLATIN; PLACEBO; SORAFENIB; TELOMERASE INHIBITOR; YTTRIUM 90;

ARTICLE; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DRUG EFFICACY; HUMAN; LIVER ANGIOGRAPHY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 42949174616     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.02.090     Document Type: Article

References (103)

1. T.H. Chen C.J. Chen M.F. Yen Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high-risk group in Taiwan Int J Cancer 98 2002 257 261
2. H. Tsukuma T. Hiyama S. Tanaka Risk factors for hepatocellular carcinoma among patients with chronic liver disease N Engl J Med 328 1993 1797 1801
3. R.F. Velazquez M. Rodriguez C.A. Navascues Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis Hepatology 37 2003 520 527
4. B.G. Choi S.H. Park J.Y. Byun The findings of ruptured hepatocellular carcinoma on helical CT Br J Radiol 74 2001 142 146
5. R.C. Eastman R.E. Carson D.G. Orloff Glucose utilization in a patient with hepatoma and hypoglycemia Assessment by a positron emission tomography J Clin Invest 89 1992 1958 1963
6. S. Sakisaka M. Watanabe H. Tateishi Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: immunohistochemical evidence Hepatology 18 1993 1357 1362
7. M. Kew Tumors of the liver D. Zakim T. Boyer Hepatology: A textbook of liver disease 1996 WB Saunders Company Philadelphia 1513
8. J. Bruix M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
9. B.H. Zhang B.H. Yang Z.Y. Tang Randomized controlled trial of screening for hepatocellular carcinoma J Cancer Res Clin Oncol 130 2004 417 422
10. J.G. Chen D.M. Parkin Q.G. Chen Screening for liver cancer: results of a randomised controlled trial in Qidong, China J Med Screen 10 2003 204 209
11. L.L. Wong W.M. Limm R. Severino Improved survival with screening for hepatocellular carcinoma Liver Transpl 6 2000 320 325
12. F. Trevisani N.S. De G. Rapaccini Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience) Am J Gastroenterol 97 2002 734 744
13. B. Zhang B. Yang Combined α-fetoprotein testing and ultrasonography as a screening test for primary liver cancer J Med Screen 6 1999 108 110
14. L. Bolondi S. Sofia S. Siringo Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis Gut 48 2001 251 259
15. J. Collier M. Sherman Screening for hepatocellular carcinoma Hepatology 27 1998 273 278
16. C.K. Kim J.H. Lim W.J. Lee Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients J Ultrasound Med 20 2001 99 104
17. F. Trevisani P.E. D'Intino A.M. Morselli-Labate Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status J Hepatol 34 2001 570 575
18. M. Sherman K.M. Peltekian C. Lee Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population Hepatology 22 1995 432 438
19. F. Trevisani P.E. D'Intino P. Caraceni Etiologic factors and clinical presentation of hepatocellular carcinoma Differences between cirrhotic and noncirrhotic Italian patients Cancer 75 1995 2220 2232
20. N. Bayati A.L. Silverman S.C. Gordon Serum α-fetoprotein levels and liver histology in patients with chronic hepatitis C Am J Gastroenterol 93 1998 2452 2456
21. A.V. Franca J.J. Elias B.L. Lima Diagnosis, staging and treatment of hepatocellular carcinoma Braz J Med Biol Res 37 2004 1689 1705
22. D. Patel N.A. Terrault F.Y. Yao Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis Clin Gastroenterol Hepatol 3 2005 75 84
23. S. Saab D. Ly J. Nieto Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model Liver Transpl 9 2003 672 681
24. D. Choi S.H. Kim J.H. Lim Detection of hepatocellular carcinoma: combined T2-weighted and dynamic gadolinium-enhanced MRI versus combined CT during arterial portography and CT hepatic arteriography J Comput Assist Tomogr 25 2001 777 785
25. M.R. Arguedas V.K. Chen M.A. Eloubeidi Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis Am J Gastroenterol 98 2003 679 690
26. J.A. Marrero H.K. Hussain H.V. Nghiem Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass Liver Transpl 11 2005 281 289
27. M. Burrel J.M. Llovet C. Ayuso MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation Hepatology 38 2003 1034 1042
28. V. de Ledinghen D. Laharie R. Lecesne Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients Eur J Gastroenterol Hepatol 14 2002 159 165
29. L. Libbrecht D. Bielen C. Verslype Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations Liver Transpl 8 2002 749 761
30. A. Rode B. Bancel P. Douek Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver J Comput Assist Tomogr 25 2001 327 336
31. M. Ebara M. Ohto Y. Watanabe Diagnosis of small hepatocellular carcinoma: correlation of MR imaging and tumor histologic studies Radiology 159 1986 371 377
32. M. Ebara M. Ohto F. Kondo Strategy for early diagnosis of hepatocellular carcinoma (HCC) Ann Acad Med Singapore 18 1989 83 89
33. G. Torzilli M. Minagawa T. Takayama Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy Hepatology 30 1999 889 893
34. J. Bruix M. Sherman J.M. Llovet Clinical management of hepatocellular carcinoma Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430
35. V. Byrnes H. Shi S. Kiryu The clinical outcome of small (<20 mm) arterially enhancing nodules on MRI in the cirrhotic liver Am J Gastroenterol 102 2007 1654 1659
36. F. Durand J.M. Regimbeau J. Belghiti Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma J Hepatol 35 2001 254 258
37. J.M. Llovet C. Bru J. Bruix Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 1999 329 338
38. J.A. Marrero R.J. Fontana A. Barrat Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort Hepatology 41 2005 707 716
39. I. Levy M. Sherman Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto Gut 50 2002 881 885
40. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma The Cancer of the Liver Italian Program (CLIP) Investigators Hepatology 31 2000 840 845
41. C. Conill E. Verger M. Salamero Performance status assessment in cancer patients Cancer 65 1990 1864 1866
42. Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial CLIP Group (Cancer of the Liver Italian Programme) Lancet 352 1998 17 20
43. A. Castells J. Bruix C. Bru Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients Gastroenterology 109 1995 917 922
44. F. Farinati Tamoxifen treatment in hepatocellular carcinoma Gastroenterology 111 1996 272 274
45. M.F. Yuen R.T. Poon C.L. Lai A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma Hepatology 36 2002 687 691
46. J.M. Llovet M. Sala L. Castells Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma Hepatology 31 2000 54 58
47. C. Grimaldi H. Bleiberg F. Gay Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial J Clin Oncol 16 1998 411 417
48. O. Dewantoro R.A. Gani N. Akbar Hepatocarcinogenesis in viral hepatitis B infection: the role of HBx and p53 Acta Med Indones 38 2006 154 159
49. H.B. El-Serag K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557 2576
50. J.M. Llovet J. Fuster J. Bruix Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation Hepatology 30 1999 1434 1440
51. Y.J. Chen S.H. Yeh J.T. Chen Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma Gastroenterology 119 2000 431 440
52. S.D. Finkelstein W. Marsh A.J. Demetris Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma Hepatology 37 2003 871 879
53. I.O. Ng X.Y. Guan R.T. Poon Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis J Pathol 199 2003 345 353
54. J.N. Vauthey G.Y. Lauwers N.F. Esnaola Simplified staging for hepatocellular carcinoma J Clin Oncol 20 2002 1527 1536
55. X.D. Zhou Z.Y. Tang B.H. Yang Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma Cancer 91 2001 1479 1486
56. I. Ikai S. Arii M. Kojiro Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey Cancer 101 2004 796 802
57. M. Shi R.P. Guo X.J. Lin Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial Ann Surg 245 2007 36 43
58. J. Bruix A.J. Hessheimer A. Forner New aspects of diagnosis and therapy of hepatocellular carcinoma Oncogene 25 2006 3848 3856
59. M. Sala M. Varela J. Bruix Selection of candidates with HCC for transplantation in the MELD era Liver Transpl 10 Suppl 2 2004 S4 S9
60. V. Mazzaferro E. Regalia R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
61. K. Shetty K. Timmins C. Brensinger Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome Liver Transpl 10 2004 911 918
62. F.Y. Yao L. Ferrell N.M. Bass Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 2001 1394 1403
63. C. Margarit A. Escartin L. Castells Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation Liver Transpl 11 2005 1242 1251
64. F.Y. Yao R. Hirose J.M. LaBerge A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation Liver Transpl 11 2005 1505 1514
65. R. Adam D. Azoulay D. Castaing Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg 238 2003 508 518
66. C.M. Lo S.T. Fan C.L. Liu The role and limitation of living donor liver transplantation for hepatocellular carcinoma Liver Transpl 10 2004 440 447
67. J.F. Trotter M. Wachs G.T. Everson Adult-to-adult transplantation of the right hepatic lobe from a living donor N Engl J Med 346 2002 1074 1082
68. R.A. Fisher L.M. Kulik C.E. Freise Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation Am J Transplant 7 2007 1601 1608
69. B. Ringe R. Pichlmayr C. Wittekind Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients World J Surg 15 1991 270 285
70. H. Ishii S. Okada H. Nose Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection Cancer 77 1996 1792 1796
71. T. Livraghi L. Bolondi S. Lazzaroni Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis A study on 207 patients Cancer 69 1992 925 929
72. R. Vilana J. Bruix C. Bru Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma Hepatology 16 1992 353 357
73. T. Livraghi L. Bolondi L. Buscarini No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis Italian Cooperative HCC Study Group J Hepatol 22 1995 522 526
74. J. Yamamoto S. Okada K. Shimada Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection Hepatology 34 2001 707 713
75. M. Ryu Y. Shimamura T. Kinoshita Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study Jpn J Clin Oncol 27 1997 251 257
76. T. Livraghi S.N. Goldberg S. Lazzaroni Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection Radiology 210 1999 655 661
77. S. Shiina T. Teratani S. Obi A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma Gastroenterology 129 2005 122 130
78. S.M. Lin C.J. Lin C.C. Lin Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4 cm Gastroenterology 127 2004 1714 1723
79. R.A. Lencioni H.P. Allgaier D. Cioni Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection Radiology 228 2003 235 240
80. T. Teratani H. Yoshida S. Shiina Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations Hepatology 43 2006 1101 1108
81. D.Q. Liu M.D. Lu J.F. Tan Microwave coagulation at different temperatures for hepatocellular carcinoma management: efficacy evaluation by enzyme histochemical staining Nan Fang Yi Ke Da Xue Xue Bao 26 2006 1149 1151
82. M.S. Chen J.Q. Li Y. Zheng A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma Ann Surg 243 2006 321 328
83. T. Livraghi F. Meloni S.M. Di Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 47 2008 82 89
84. J.M. Llovet M.I. Real X. Montana Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739
85. J. Bruix M. Sala J.M. Llovet Chemoembolization for hepatocellular carcinoma Gastroenterology 127 Suppl 1 2004 S179 S188
86. J.M. Llovet J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 2003 429 442
87. L.M. Kulik B. Atassi L. van Holsbeek Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation J Surg Oncol 94 2006 572 586
88. J. Llovet Sorafenib improves survival in advanced hepatocellular carcinoma (HCC): results of a phase III randomized placebo-controlled trial (SHARP trial) J Clin Oncol 25 18S [June 20 Suppl] 2007 LBA1
89. T. Hampton Cancer drug trials show modest benefit: drugs target liver, gastric, head and neck cancers JAMA 298 2007 273 275
90. P.A. Philip M.R. Mahoney C. Allmer Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer J Clin Oncol 23 2005 6657 6663
91. M.W. Djojosubroto A.C. Chin N. Go Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma Hepatology 42 2005 1127 1136
92. J. Xu Z.Y. Shen X.G. Chen A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation Hepatology 45 2007 269 276
93. A. Quaglia M. McStay K. Stoeber Novel markers of cell kinetics to evaluate progression from cirrhosis to hepatocellular carcinoma Liver Int 26 2006 424 432
94. M. Fiorentino A. Altimari M. Ravaioli Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation Clin Cancer Res 10 2004 1789 1795
95. M.C. Ho J.J. Lin C.N. Chen A gene expression profile for vascular invasion can predict the recurrence after resection of hepatocellular carcinoma: a microarray approach Ann Surg Oncol 13 2006 1474 1484
96. Y. Hoshida M. Moriyama M. Otsuka Gene expressions associated with chemosensitivity in human hepatoma cells Hepatogastroenterology 54 2007 489 492
97. R. Tateishi S. Shiina H. Yoshida Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers Hepatology 44 2006 1518 1527
98. J.M. Llovet Y. Chen E. Wurmbach A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis Gastroenterology 131 2006 1758 1767
99. J.A. Davila H.B. El-Serag Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study Clin Gastroenterol Hepatol 4 2006 104 110
100. H.B. El-Serag Translational research: the study of community effectiveness in digestive and liver disorders Gastroenterology 132 2007 8 10
101. H.B. El-Serag A.B. Siegel J.A. Davila Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study J Hepatol 44 2006 158 166
102. A.B. Siegel R.B. McBride H.B. El-Serag Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998–2002 Am J Gastroenterol 103 2008 120 127
103. J. Bruix A. Castells J. Bosch Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure Gastroenterology 111 1996 1018 1022